1. Home
  2. ZKH vs YDES Comparison

ZKH vs YDES Comparison

Compare ZKH & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ZKH Group Limited

ZKH

ZKH Group Limited

N/A

Current Price

$2.92

Market Cap

465.1M

Sector

N/A

ML Signal

N/A

YDES

YD Bio Limited Ordinary Shares

N/A

Current Price

$4.69

Market Cap

543.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
ZKH
YDES
Founded
1998
2013
Country
China
Taiwan
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
465.1M
543.0M
IPO Year
2022
2024

Fundamental Metrics

Financial Performance
Metric
ZKH
YDES
Price
$2.92
$4.69
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
111.6K
42.4K
Earning Date
05-19-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$9.02
N/A
Revenue Next Year
$10.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.92
$1.70
52 Week High
$3.90
$25.00

Technical Indicators

Market Signals
Indicator
ZKH
YDES
Relative Strength Index (RSI) 53.65 78.79
Support Level $2.88 $4.73
Resistance Level $2.98 $5.36
Average True Range (ATR) 0.10 0.48
MACD -0.01 0.28
Stochastic Oscillator 76.81 92.58

Price Performance

Historical Comparison
ZKH
YDES

About ZKH ZKH Group Limited

ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. Majority of the revenues are derived from the PRC.

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

Share on Social Networks: